Silk Road Medical Inc (NASDAQ:SILK) currently has a daily average trading volume of 1.68M but it saw 5069411 shares traded in last market. With a market cap of 1.10B USD, the company’s current market price of $27.11 came rising about 0.18 while comparing to the previous closing price of $27.06. In past 52 weeks, the stock remained buoying in the range of price level as high as $27.19 and as low as $6.08. In the recent trading on the day, stock has struck highest price mark of $26.7 while lowest mark touched by it was $27.125.
Taking a look at 20-day trading activity of Silk Road Medical Inc (SILK) gives us an average price of $27.05, while its current price level is -0.29% below from 52-week high level whereas it is 345.89% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $25.46 while that of 200 days or SMA-200 reads an average of $17.33. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.71% during that period while stretching the period over a month that decreases to 0.42%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 69.99 which implies that the stock is in neutral territory.
Argus upgraded its recommendation for the stock as a “Buy” from “Hold” on March 07, 2024 while assigning a price target of $24. Stifel issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $9 and $20.
Over the week, SILK’s stock price is moving 0.22% up while it is 0.22% when we observe its performance for the past one month. Year-to-date it is 120.95% up and over the past year, the stock is showing an upside performance of 34.94%.
Currently, Silk Road Medical Inc’s total number of outstanding shares is 39.17M. Company’s return on investment (ROI) stands at -23.82% and return on equity (ROE) at -36.45%. Stock’s beta reads 1.49. Stock has a price to book (P/B) ratio of 7.12 while price to sale or P/S ratio amounts to 5.75. Its return on asset (ROA) is -21.21% on average.
